Head and Neck Cancer — Adjuvant Cetuximab and Chemoradiation in Head and Neck Cancer
Citation(s)
Multicenter, Open-label Phase II Trial on Post-surgery Chemoradiation in Combination With Cetuximab in Squamous Cell Carcinoma of the Head and Neck With High Risk of Locoregional Recurrence.